Cover Image

Phase III trial of bortezomib, cyclophosphamide, dexamethasone (VCD) versus bortezomib, doxorubicin, dexamethasone (PAd) in newly-diagnosed myeloma

Saved in:
Bibliographic Details
Other Authors: Mai, Elias K. (Other) , Raab, Marc-Steffen (Other) , Neben, Kai (Other) , Goldschmidt, Hartmut (Other) , Bertsch, Uta (Other) , Jauch, Anna (Other) , Schurich, Bärbel (Other) , Merz, Maximilian (Other) , Hügle-Dörr, Barbara (Other) , Seckinger, Anja (Other) , Hose, Dirk (Other) , Hillengaß, Jens (Other)
Format: Article (Journal)
Language:English
Published: 2015
In: Leukemia
Year: 2015, Volume: 29, Issue: 8, Pages: 1721-1729
ISSN:1476-5551
DOI:10.1038/leu.2015.80
Online Access:Resolving-System, Volltext: http://dx.doi.org/10.1038/leu.2015.80
Verlag, Volltext: http://www.nature.com/leu/journal/vaop/naam/abs/leu201580a.html
Get full text
Author Notes:E. K. Mai, U. Bertsch, J. Dürig, C. Kunz, M. Haenel, I. W. Blau, M. Munder, A. Jauch, B. Schurich, T. Hielscher, M. Merz, B. Huegle-Doerr, A. Seckinger, D. Hose, J. Hillengass, M. S. Raab, K. Neben, H.-W. Lindemann, M. Zeis, C. Gerecke, I. G. H. Schmidt-Wolf, K. Weisel, C. Scheid, H. Salwender and H. Goldschmidt
Description
Item Description:Gesehen am 24.04.2015
Physical Description:Online Resource
ISSN:1476-5551
DOI:10.1038/leu.2015.80

Similar Items